Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $452.15 million. The enterprise value is $151.17 million.
Important Dates
The next confirmed earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 80.03 million shares outstanding. The number of shares has decreased by -3.29% in one year.
| Current Share Class | 80.03M |
| Shares Outstanding | 80.03M |
| Shares Change (YoY) | -3.29% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 15.91% |
| Owned by Institutions (%) | 63.67% |
| Float | 59.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.82, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.82 |
| Quick Ratio | 7.59 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.34% and return on invested capital (ROIC) is -31.28%.
| Return on Equity (ROE) | -44.34% |
| Return on Assets (ROA) | -28.75% |
| Return on Invested Capital (ROIC) | -31.28% |
| Return on Capital Employed (ROCE) | -65.13% |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.88M |
| Employee Count | 55 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +90.88% in the last 52 weeks. The beta is 0.38, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +90.88% |
| 50-Day Moving Average | 5.58 |
| 200-Day Moving Average | 3.97 |
| Relative Strength Index (RSI) | 52.64 |
| Average Volume (20 Days) | 259,935 |
Short Selling Information
The latest short interest is 7.69 million, so 9.60% of the outstanding shares have been sold short.
| Short Interest | 7.69M |
| Short Previous Month | 7.59M |
| Short % of Shares Out | 9.60% |
| Short % of Float | 12.85% |
| Short Ratio (days to cover) | 17.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | -146.53M |
| Operating Income | -179.40M |
| Pretax Income | -164.51M |
| Net Income | -158.35M |
| EBITDA | -178.98M |
| EBIT | -179.40M |
| Earnings Per Share (EPS) | -$1.94 |
Full Income Statement Balance Sheet
The company has $301.83 million in cash and $843,000 in debt, with a net cash position of $300.99 million or $3.76 per share.
| Cash & Cash Equivalents | 301.83M |
| Total Debt | 843,000 |
| Net Cash | 300.99M |
| Net Cash Per Share | $3.76 |
| Equity (Book Value) | 275.43M |
| Book Value Per Share | 3.53 |
| Working Capital | 271.21M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -132.03M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 416,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -132.03M |
| FCF Per Share | -$1.65 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.29% |
| Shareholder Yield | 3.29% |
| Earnings Yield | -35.02% |
| FCF Yield | -29.20% |
Analyst Forecast
The average price target for AVIR is $10.00, which is 76.99% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 76.99% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |